Genomic dataset platform used for AI‑driven cancer research
Price
$8,100,000,000
Date
2018
Buyer
Roche
Seller
Foundation Medicine
Type
DATASET_ACQUISITION
Region
Global
Market Context
Roche acquired Foundation Medicine to obtain genomic datasets used for AI‑enabled precision medicine.
Term
Acquisition
(Permanent)
Confidence:
High
Citation:
DatFlash (2026).
"Genomic dataset platform used for AI‑driven cancer research"
https://www.datflash.com/transaction/roche-foundation-medicine-genomic-dataset-platform-used-for-aidriven-cancer-research-2018
https://www.datflash.com/transaction/roche-foundation-medicine-genomic-dataset-platform-used-for-aidriven-cancer-research-2018